Buprenorphine: an overview for clinicians
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Issue brief (California HealthCare Foundation)
- Author(s):
- Steiger, Scott, author DeFries, Triveni, author
- Contributor(s):
- California HealthCare Foundation, issuing body.
- Publication:
- [Oakland, California] : California Health Care Foundation, August 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Buprenorphine -- therapeutic use Opiate Substitution Treatment Opioid-Related Disorders -- drug therapy Ambulatory Care Buprenorphine -- administration & dosage Buprenorphine -- adverse effects Drug and Narcotic Control Emergency Service, Hospital Health Services Accessibility Mental Health Services Methadone -- therapeutic use Naltrexone -- therapeutic use Pain -- drug therapy Prescription Drug Diversion Prisons State Government Telemedicine Humans California United States
- Genre(s):
- Technical Report
- Abstract:
- Buprenorphine, an FDA-approved medication for addiction treatment and pain relief, cuts opioid overdose death rates in half. Yet nearly 80% of Americans with opioid use disorder (OUD) do not receive buprenorphine or other medication-assisted treatment (MAT). This document provides answers to frequently asked questions, aiming to increase prescriber comfort with prescribing buprenorphine throughout the health care system. Once the basics are mastered, buprenorphine can be as straightforward to prescribe as medications for other medical conditions.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-ND license. (More information)
- Extent:
- 1 online resource (1 PDF file (17 pages)).
- NLM Unique ID:
- 101758687 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101758687